Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company
Because losing at least 5% of fasting body weight through lifestyle intervention during the 4- to 12-week run-in was a condition for their continued participation in the randomized treatment period, the results may not reflect those expected in the general population
Food and Drug Administration (FDA) and European Medicines Agency (EMA) approval in 2019 and 2020, respectively, for the second-line treatment of adults with insufficiently controlled T2D to improve glycaemic control as an adjunct to diet and exercise at the once-daily oral doses of 3, 7 and 14 mg [22, 23]
V., Zamboni, P., & Mahajan, R
US$ 23.28
US$ 22.57
US$ 21.38
US$ 26.35
